Lead sponsor
Sciwind Biosciences APAC CO Pty. Ltd.
3 GLP-1 and incretin trials led. Source: ClinicalTrials.gov, as of July 6, 2026.
3
Trials led
0
Ongoing
357
Total enrollment
3
Sites
Distinct sites across this sponsor's lead trials. A site running several of them counts once, matching the map. Total enrollment sums each trial's reported enrollment, whether planned or actual.
Portfolio
How this sponsor's trials break down
Trials by phase
Phase 1
2
Phase 2
1
Trials by status
Completed
3
Trials led
TrialEligibility highlightPhaseStatusEnrollment
Effects of XW003 Versus Liraglutide on Body Weight of Adult Participants With ObesityBMI 30-40Ph 2Completed206